Mesoblast Newsroom

Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $18

Moomoo NewsNov 6 08:39 ET

Buy Rating for Mesoblast Driven by Promising Market Opportunities and Upcoming PDUFA Date for Ryoncil

TipRanksNov 6 07:47 ET

Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsOct 31 07:31 ET

Maxim Group Upgrades Mesoblast(MESO.US) to Buy Rating, Cuts Target Price to $12

Moomoo NewsSep 24 08:32 ET

Bell Potter Sticks to Their Buy Rating for Mesoblast Limited (MEOBF)

TipRanksAug 29 22:10 ET

Mesoblast Analyst Ratings

BenzingaAug 29 11:18 ET

Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Announces Target Price $11

Moomoo NewsAug 29 07:32 ET

Mesoblast (MESO) Receives a Buy From Piper Sandler

TipRanksAug 29 06:52 ET

Mesoblast Price Target Raised to $11.00/Share From $4.00 by Piper Sandler

Dow JonesJul 23 14:07 ET

Mesoblast Analyst Ratings

BenzingaJul 23 13:57 ET

Piper Sandler Upgrades Mesoblast(MESO.US) to Buy Rating

Moomoo NewsJul 23 13:32 ET

Mesoblast Limited (MEOBF) Was Downgraded to a Hold Rating at Jefferies

TipRanksJul 18 08:23 ET

Mesoblast Analyst Ratings

BenzingaJun 20 13:42 ET

Mesoblast Analyst Ratings

BenzingaJun 4 13:22 ET

Analysts Offer Insights on Healthcare Companies: Aprea Therapeutics (APRE), Biogen (BIIB) and Mesoblast Limited (OtherMEOBF)

TipRanksMar 27 08:25 ET

Mesoblast (MESO) Gets a Hold From Piper Sandler

TipRanksMar 12 06:36 ET

Mesoblast Limited (MEOBF) Receives a Buy From Jefferies

TipRanksMar 3 07:16 ET

Mesoblast (MESO) Gets a Hold From Piper Sandler

TipRanksFeb 29 07:48 ET

Jefferies Keeps Their Buy Rating on Mesoblast Limited (MEOBF)

TipRanksDec 26, 2023 07:38 ET

Analysts Are Bullish on These Healthcare Stocks: Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF), Mesoblast Limited (MEOBF)

TipRanksDec 24, 2023 07:51 ET